Followers | 305 |
Posts | 69706 |
Boards Moderated | 4 |
Alias Born | 02/16/2008 |
Wednesday, February 22, 2017 10:39:25 AM
Conclusion
We are very pleased with the progress that OWCP made during 2016, and look forward to further significant accomplishments in 2017.
Most importantly, we're looking forward to beginning the commercial sales of our psoriasis cream, which will hopefully be launched in the United States and Europe.
We are also pleased that OWCP was able to receive a $300,000 non-dilutive loan from Medmar to be repaid from royalties from the sale of OWC's psoriasis cream in the U.S.
The $300,000 investment fromMichepro Holding for OWCP's products in Europe, is significant as it also establishes a joint venture company in Europe, owned by Michepro and OWCP, to manufacture and distribute OWCP's products, starting with our psoriasis cream for the European market.
OWCP will continue to update and keep you informed regarding our progress this year.
http://www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-issues-annual-letter-to-shareholders-610914665.html
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM